Local application of alendronate controls bone formation and β-tricalcium phosphate resorption induced by recombinant human bone morphogenetic protein-2. [electronic resource]
Producer: 20210831Description: 528-536 p. digitalISSN:- 1552-4965
- Alendronate -- pharmacology
- Animals
- Bone Density Conservation Agents -- pharmacology
- Bone Morphogenetic Protein 2 -- pharmacology
- Bone Resorption -- drug therapy
- Calcium Phosphates -- metabolism
- Female
- Humans
- Osteogenesis -- drug effects
- Rabbits
- Recombinant Proteins -- pharmacology
- Transforming Growth Factor beta -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.